NorFalk
PrivateLast Round
Convertible Debt
Mar 7, 2024
Total Funding Raised
$1.98M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NorFalk operates in Healthcare & Life Sciences and is based in Denmark. Its latest recorded funding round was a Pre Seed round in June 2023.
NorFalk is a biotechnology company that develops and produces sustainable, bio-based surfactants as alternatives to fossil-derived or palm oil-based ingredients for the cosmetics and personal care industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NorFalk Comparables
Compare NorFalk with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AmphiStar | 86% | |
| Holiferm | 83% | |
| Dispersa | 83% |
For institutional investors. Book with your work email.
NorFalk Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Mar 7, 2024 | ||||
| Pre Seed | Jun 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NorFalk Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chemstars | Pre Seed |
| BioInnovation Institute | Pre Seed, Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 197% MoM, reaching 3.1K.
- Jan 30, 2026
Monthly visitors grew 138% MoM.
For institutional investors. Book with your work email.
NorFalk Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NorFalk's valuation, stock price, and market status.
Is NorFalk a public or private company?
NorFalk is a private company.
What is the current stock price of NorFalk?
NorFalk is a private company, so its shares have no public market price. Caplight tracks NorFalk's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NorFalk worth (valuation)?
Valuation information for NorFalk is not publicly available.
Can I buy NorFalk stock?
NorFalk shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NorFalk's last funding round?
NorFalk's most recent funding round was Convertible Debt on March 7, 2024.
Who are the main investors in NorFalk?
Key investors in NorFalk include BioInnovation Institute.
Will NorFalk IPO soon?
No public IPO plans have been announced for NorFalk.
How can I track NorFalk secondary market activity?
Caplight tracks bids, offers, and trades in NorFalk's shares on secondary markets.